Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$7.5 - $16.8 $3.32 Million - $7.44 Million
-442,769 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$12.38 - $17.47 $249,320 - $351,828
-20,139 Reduced 4.35%
442,769 $7.27 Million
Q3 2019

Nov 08, 2019

SELL
$12.27 - $15.79 $52,810 - $67,960
-4,304 Reduced 0.92%
462,908 $6.15 Million
Q2 2019

Jul 25, 2019

BUY
$13.37 - $18.85 $602,599 - $849,588
45,071 Added 10.68%
467,212 $6.58 Million
Q1 2019

May 08, 2019

SELL
$17.59 - $31.05 $763,634 - $1.35 Million
-43,413 Reduced 9.33%
422,141 $7.77 Million
Q4 2018

Feb 05, 2019

BUY
$18.97 - $31.47 $450,309 - $747,034
23,738 Added 5.37%
465,554 $12.2 Million
Q3 2018

Nov 13, 2018

SELL
$18.25 - $23.0 $149,741 - $188,715
-8,205 Reduced 1.82%
441,816 $10.1 Million
Q2 2018

Aug 07, 2018

SELL
$13.95 - $19.15 $12.6 Million - $17.3 Million
-902,555 Reduced 66.73%
450,021 $8.57 Million
Q1 2018

May 08, 2018

SELL
$14.05 - $20.2 $274,185 - $394,203
-19,515 Reduced 1.42%
1,352,576 $22.8 Million
Q4 2017

Feb 12, 2018

BUY
$12.85 - $18.1 $767,877 - $1.08 Million
59,757 Added 4.55%
1,372,091 $20.9 Million
Q3 2017

Nov 08, 2017

BUY
$15.4 - $18.85 $20.2 Million - $24.7 Million
1,312,334
1,312,334 $23.5 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $264M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.